Evaluation of the sedative effects and pharmacokinetics of detomidine gel administered intravaginally to horses.

The research studied the effects and pharmacokinetics of a sedative gel, detomidine, when applied intravaginally to horses. The findings suggest detomidine gel, when administered in this way, provides clinically significant sedation and can be used effectively in mares.

Research Methodology

Exploring the effects and behavior of detomidine gel when administered intravaginally to horses, the experiment utilised a group of six healthy adult mares, weighing approximately 494 ± 56 kgs.

• The experimental design was randomized, masked, and crossed-over, reported in two parts. The mares were either given detomidine hydrochloride (10 μg kg) intravenously (treatment IV) or detomidine gel (40 μg kg) intravaginally (treatment IVG), with a week’s gap between the two treatments.
• Behavioral changes like sedation, ataxia, muzzle-floor distance and heart rate (HR) were evaluated at 15-minute intervals for 240 minutes.
• Venous blood samples were collected at several time intervals post administration and were analyzed for detomidine and its metabolites using sophisticated techniques, such as liquid chromatography-tandem mass spectrometry.

Results and Analysis

The data was thoroughly analyzed over time and between treatments using mixed model analysis. Importantly, the detomidine concentrations highly corresponded with the sedation score.

• Sedation timeframes were shorter with intravenous detomidine (119 ± 16 minutes) than with intravaginal administration (188 ± 22 minutes).
• Ataxia scores, indicative of uncoordination and imbalance, remained high for a longer duration in the mares with intravaginal gel application, indicating a longer-lasting sedative effect.
• Heart rates for both treatments were lower than normal for a duration, but there was no significant difference between the two treatments.
• The mean maximum plasma concentrations, time to maximum concentration and bioavailability for detomidine gel administered intravaginally was 8.57 ng mL, 0.37 hour and 25%, respectively.

Conclusions

Conclusively, the intravaginally administered detomidine gel yielded clinically important sedation in mares. Therefore, the method was identified as a viable way of detomidine gel delivery in mares, with further implications for its practical use in a veterinary setting.